Argenx is a biotechnology company focused on developing innovative immunology solutions, particularly through antibody engineering and clinical trials to treat severe autoimmune diseases
Argenx is a biotechnology company focused on developing innovative immunology solutions, particularly through antibody engineering and clinical trials to treat severe autoimmune diseases.
The top three firms on F4's Biotech & Life Sciences investor list.